Director/PDMR Shareholding

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN

Clinigen Group plc

2 October 2013

DIRECTOR'S DEALING

Clinigen Group plc ("Clinigen" or the "Company", AIM: CLIN), announces that it was informed on 1 October 2013 that, following yesterday morning's placing, as a result of additional late US institutional demand, on 1 October 2013, Peter George, Chief Executive Officer of the Company, sold a further 500,000 ordinary shares of 0.1p each in the Company at a price of 410p per share.

Following this transaction (approval for which, in the context of the lock-in arrangement to which Mr George is subject, was provided by Numis Securities Limited and Peel Hunt LLP), Mr George is interested in a total of 5,557,242 ordinary shares of 0.1p each in the Company representing 6.7 per cent. of the Company's issued share capital.

As disclosed in yesterday's Result of Placing RNS announcement, Peter George and the two other Directors who sold shares in yesterday morning's placing, Robin Sibson and Shaun Chilton, have each undertaken (subject to customary exceptions) not to dispose of any further shares in the Company for a period of 180 days from 1 October 2013. The orderly market provisions, which were put in place at the time of the Company's IPO and which apply to all of the Directors and employees who sold shares in yesterday morning's placing, will continue in force until their scheduled expiry in September 2014.

- Ends -

Enquiries: